Canlyniadau chwilio am the

Which forms to fill out to request approval, and what happens next. 

Find previous editions of our Partner newsletter

Applying for non-objection when using protected titles in company names

We are concerned to hear that people with Type 2 diabetes are experiencing problems accessing GLP-1 receptor agonists (GLP-1 RAs).

This policy statement sets out our broad approach to developing memorandums of understanding (MoUs) with other organisations.

We have produced a guide to help education providers and others understand how to engage with, and where required, seek approval from HCPC.

We are consulting on changes to our standards for prescribing until Friday 4 January 2019 and we are keen to hear your views

We recognise that, due to unavoidable circumstances, some registrants may need to defer (put off) their audit.